TIANYIN PHARMACEUTICAL CO., INC.: 10-Q filed 2013-02-14

Name: TIANYIN PHARMACEUTICAL CO., INC.: 10-Q filed 2013-02-14
Creator: TIANYIN PHARMACEUTICAL CO., INC.

What TIANYIN PHARMACEUTICAL CO., INC. reported in its quarterly report filed 2013-02-14 (fiscal Q2 2013): 52 published measures, 143 facts as tagged in accession 0001213900-13-000711.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-02-14
Fiscal period: fiscal Q2 2013
Accession: 0001213900-13-000711 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TIANYIN PHARMACEUTICAL CO., INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-12-31	102,301,797	USD
At 2012-06-30	104,317,539	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-12-31	9,281,338	USD
At 2012-06-30	14,798,092	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-12-31	92,778,682	USD
At 2012-06-30	89,241,421	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-12-31	25,439,653	USD
At 2012-06-30	35,152,295	USD
At 2011-12-31	36,908,404	USD
At 2011-06-30	31,724,906	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,863,950	USD	92
2012-07-01 to 2012-12-31	3,405,567	USD	184
2011-10-01 to 2011-12-31	1,737,605	USD	92
2011-07-01 to 2011-12-31	3,262,845	USD	184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-659,687	USD	184
2011-07-01 to 2011-12-31	7,914,691	USD	184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	1,002,716	USD	184
2011-07-01 to 2011-12-31	2,836	USD	184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	17,603,298	USD	92
2012-07-01 to 2012-12-31	33,574,995	USD	184
2011-10-01 to 2011-12-31	18,236,701	USD	92
2011-07-01 to 2011-12-31	35,765,279	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	3,537,449	USD	184
2011-07-01 to 2011-12-31	-1,536,444	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-12,630,295	USD	184
2011-07-01 to 2011-12-31	-2,353,074	USD	184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-12-31	48,427,896	USD
At 2012-06-30	45,022,329	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	29,332,791	shares	92
2012-07-01 to 2012-12-31	29,332,791	shares	184
2011-10-01 to 2011-12-31	29,396,276	shares	92
2011-07-01 to 2011-12-31	29,396,276	shares	184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	29,332,791	shares	92
2012-07-01 to 2012-12-31	29,332,791	shares	184
2011-10-01 to 2011-12-31	29,396,276	shares	92
2011-07-01 to 2011-12-31	29,396,276	shares	184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	0.06	USD/shares	92
2012-07-01 to 2012-12-31	0.12	USD/shares	184
2011-10-01 to 2011-12-31	0.06	USD/shares	92
2011-07-01 to 2011-12-31	0.11	USD/shares	184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	0.06	USD/shares	92
2012-07-01 to 2012-12-31	0.12	USD/shares	184
2011-10-01 to 2011-12-31	0.06	USD/shares	92
2011-07-01 to 2011-12-31	0.11	USD/shares	184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	668,762	USD	92
2012-07-01 to 2012-12-31	1,251,810	USD	184
2011-10-01 to 2011-12-31	556,590	USD	92
2011-07-01 to 2011-12-31	1,175,657	USD	184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-12-31	32,848,630	USD
At 2012-06-30	26,458,349	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	17,730	USD	184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	2,598,418	USD	92
2012-07-01 to 2012-12-31	4,743,221	USD	184
2011-10-01 to 2011-12-31	2,053,849	USD	92
2011-07-01 to 2011-12-31	4,199,735	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-12-31	43,361,688	USD
At 2012-06-30	56,900,964	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	113,468	USD	92
2012-07-01 to 2012-12-31	221,872	USD	184
2011-10-01 to 2011-12-31	82,930	USD	92
2011-07-01 to 2011-12-31	132,775	USD	184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-12-31	9,281,338	USD
At 2012-06-30	14,798,092	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-12-31	1,253,655	USD
At 2012-06-30	1,436,369	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2012-12-31	206,310	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2012-12-31	20,584,589	USD
At 2012-06-30	20,958,226	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-12-31	10,500,199	USD
At 2012-06-30	11,272,367	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2011-11-01 to 2011-11-30	24,338	USD	30

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	4,205,364	USD	92
2012-07-01 to 2012-12-31	8,304,265	USD	184
2011-10-01 to 2011-12-31	4,034,453	USD	92
2011-07-01 to 2011-12-31	7,741,616	USD	184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-12-31	6,970,478	USD
At 2012-06-30	5,863,013	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	6,803,782	USD	92
2012-07-01 to 2012-12-31	13,047,486	USD	184
2011-10-01 to 2011-12-31	6,088,302	USD	92
2011-07-01 to 2011-12-31	11,941,351	USD	184

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	10,799,516	USD	92
2012-07-01 to 2012-12-31	20,527,509	USD	184
2011-10-01 to 2011-12-31	12,148,399	USD	92
2011-07-01 to 2011-12-31	23,823,928	USD	184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	222,423	USD	92
2012-07-01 to 2012-12-31	438,353	USD	184
2011-10-01 to 2011-12-31	210,784	USD	92
2011-07-01 to 2011-12-31	421,499	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-12-31	29,332,791	shares
At 2012-06-30	29,332,791	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-12-31	30,122,632	USD
At 2012-06-30	30,104,902	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-12-31	8,214,490	USD
At 2012-06-30	8,100,526	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2012-12-31	93,020,459	USD
At 2012-06-30	89,519,447	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2012-12-31	28,573,562	USD
At 2012-06-30	27,535,658	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-12-31	4,389,952	USD
At 2012-06-30	3,613,310	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2012-12-31	20,584,589	USD
At 2012-06-30	20,958,226	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-12-31	15,000	USD
At 2012-06-30	149,782	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,848,030	USD	92
2012-07-01 to 2012-12-31	3,368,983	USD	184
2011-10-01 to 2011-12-31	1,681,570	USD	92
2011-07-01 to 2011-12-31	3,188,787	USD	184

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	2,090,054	USD	92
2012-07-01 to 2012-12-31	3,519,531	USD	184
2011-10-01 to 2011-12-31	2,301,130	USD	92
2011-07-01 to 2011-12-31	4,518,450	USD	184

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,863,950	USD	92
2012-07-01 to 2012-12-31	3,405,567	USD	184
2011-10-01 to 2011-12-31	1,737,605	USD	92
2011-07-01 to 2011-12-31	3,262,845	USD	184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,097,854	USD	92
2012-07-01 to 2012-12-31	2,219,387	USD	184
2011-10-01 to 2011-12-31	1,022,039	USD	92
2011-07-01 to 2011-12-31	2,041,161	USD	184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	387,488	USD	92
2012-07-01 to 2012-12-31	771,743	USD	184
2011-10-01 to 2011-12-31	72,196	USD	92
2011-07-01 to 2011-12-31	200,809	USD	184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	1,171,649	USD	184
2011-07-01 to 2011-12-31	518,131	USD	184

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	200,457	USD	92
2012-07-01 to 2012-12-31	399,906	USD	184
2011-10-01 to 2011-12-31	159,267	USD	92
2011-07-01 to 2011-12-31	317,322	USD	184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-81,626	USD	92
2012-07-01 to 2012-12-31	-122,428	USD	184
2011-10-01 to 2011-12-31	184,311	USD	92
2011-07-01 to 2011-12-31	164,709	USD	184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	221,872	USD	184
2011-07-01 to 2011-12-31	132,775	USD	184

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	1,390,391	USD	184
2011-07-01 to 2011-12-31	1,560,653	USD	184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-786,045	USD	184
2011-07-01 to 2011-12-31	-46,185	USD	184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	1,099,581	USD	184
2011-07-01 to 2011-12-31	-908,557	USD	184

Inspect the source

Entity: TIANYIN PHARMACEUTICAL CO., INC. / CIK 0001362718
Captured: 2026-09-22 19:45 UTC
SEC response SHA-256: 906628a22ccc64c913be7c41e1b47cf109b535396d641f5e43d99086a9971e90

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001362718.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))